Henry T Lynch MD, completed his MA in psychology at Denver University and was nearing completion of a PhD in human genetics at the University of Texas in Austin, when he entered medical school at the University of Texas Medical Branch in Galveston, from which he received his MD in 1960. He completed residency in internal medicine and medical oncology. He was on the faculty of the University of Texas MD Anderson Cancer Center in Houston before going to Creighton University School of Medicine in Omaha, Nebraska, in 1967, as Chairman of Preventive Medicine, advancing to full professor in 1972.
During the 1960’s, when cancer was considered an almost solely environmentally-caused disease, Dr Lynch demonstrated Mendelian inheritance patterns for what is now known as Lynch syndrome, and for the hereditary breast-ovarian cancer (HBOC) syndrome, which he subsequently helped link to the BRCA1 and BRCA2 genes. He provided early evidence for familial atypical multiple mole melanoma (FAMMM) and its association with pancreatic cancer when a CDKN2A mutation is present.